Novo Nordisk - ADR

NVO

$92.60

+39.6% (1 year change)

Market Cap

$162 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$61.90 - $92.18

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

0.0x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$1.43 (1.57%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $162 Billion
Enterprise Value -
Dividend Yield $1.43 (1.57%)
1 Year Return +41.1%
52-Week High $92.18
52-Week Low $61.90
Beta 0.53
Outstanding Shares 1.77 Billion
Avg 30 Day Volume 888 Thousand

Valuation

P/E Ratio 0.0
PEG -
Earnings per Share $0.00
Price to Sales Ratio -
Price to Book Ratio -
Revenue to Enterprise Value -
EBIT to Enterprise Value -
Total Debt to Enterprise Value -
Debt to Equity -

Profitability

Revenue -
Gross Profit -
EBIT -
Net Income -
Profit Margin -
Quarterly Earnings Growth (YoY) -
Return on Equity -
Return on Assets -
Return on Invested Capital -

News

Let the games begin- Novo Nordisk takes the gold in Cowens R&D pentathlon Endpoints News

Let the games begin- Novo Nordisk takes the gold in Cowens R&D pentathlon Endpoints News

Let the games begin: Novo Nordisk takes the gold in Cowen''s ''R&D pentathlon'' Endpoints News

Endpoints News Endpoints News, about 22 hours ago
Global Glucagon Drug Market (2021-2026) | Latest COVID19 Impact Analysis | Know About Brand Players - Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs

Global Glucagon Drug Market (2021-2026) | Latest COVID19 Impact Analysis | Know About Brand Players - Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs

The recent report titled Global Glucagon Drug Market and forecast to 2026 published by Reportsweb is a focused study encompassing the market segmentation primarily based on type and application. Th...

OpenPR OpenPR, 3 days ago
Antidiabetic Biguanides Market 2021 SWOT Analysis, Competitive Landscape and Significant Growth | Top Brands:Pfizer, Novo Nordisk, Merck & Co, AstraZeneca, Takeda Pharmaceuticals, GlaxoSmithKline,

Antidiabetic Biguanides Market 2021 SWOT Analysis, Competitive Landscape and Significant Growth | Top Brands:Pfizer, Novo Nordisk, Merck & Co, AstraZeneca, Takeda Pharmaceuticals, GlaxoSmithKline,

This report studies the Antidiabetic Biguanides Market with many aspects of the industry such as market size, market status, market trends and forecast. The report also provides brief information o...

Jumbo News Jumbo News, 6 days ago